Vaccine Booster

India, with its vast population and diverse climatic conditions, faces the threat of a tripledemic during seasonal changes. Understanding these viruses and knowing how to prevent and treat them is crucial in staying healthy.

Billionaire Elon Musk on Tuesday claimed that his Covid vaccine shot almost sent him to the hospital.

Moderna said Wednesday its updated fall Covid booster, which is pending approval from the Food and Drug Administration, performed well against the highly mutated BA.2.86 variant.

Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.

Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute's Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday.

The Covid vaccines in use in India are providing cover for the original Wuhan strain but if the need for another booster dose is felt as new variants emerge, it should be able to provide protection against all circulating as well as future strains

Earlier this month, US health officials said they had detected the possible link to ischemic strokes in people over age 65 who received the newer booster shots.

The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.

China needs a good COVID-19 booster vaccine like Covovax, but so far there hasn't been a positive response from China, said Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday.

Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.

The Serum Institute of India is working to market its two key vaccines for Covid -- Covovax and Covishield -- in China, which is seeing a resurgence of the pandemic.

An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.

Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.

The booster dose of COVID-19 vaccine is safe, according to a study published in The Lancet Respiratory Medicine that monitored heart measures through smartwatches. Researchers at Tel Aviv University equipped close to 5,000 Israelis with smartwatches.

Those aged 60+ are eligible for free dose at government facilities, while it costs Rs 400 for all age groups at private centres

India, with its vast population and diverse climatic conditions, faces the threat of a tripledemic during seasonal changes. Understanding these viruses and knowing how to prevent and treat them is crucial in staying healthy.

Billionaire Elon Musk on Tuesday claimed that his Covid vaccine shot almost sent him to the hospital.

Moderna said Wednesday its updated fall Covid booster, which is pending approval from the Food and Drug Administration, performed well against the highly mutated BA.2.86 variant.

Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.

Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute's Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday.

The Covid vaccines in use in India are providing cover for the original Wuhan strain but if the need for another booster dose is felt as new variants emerge, it should be able to provide protection against all circulating as well as future strains

Earlier this month, US health officials said they had detected the possible link to ischemic strokes in people over age 65 who received the newer booster shots.

The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.

China needs a good COVID-19 booster vaccine like Covovax, but so far there hasn't been a positive response from China, said Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday.

Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.

The Serum Institute of India is working to market its two key vaccines for Covid -- Covovax and Covishield -- in China, which is seeing a resurgence of the pandemic.

An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.

Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.

The booster dose of COVID-19 vaccine is safe, according to a study published in The Lancet Respiratory Medicine that monitored heart measures through smartwatches. Researchers at Tel Aviv University equipped close to 5,000 Israelis with smartwatches.

Those aged 60+ are eligible for free dose at government facilities, while it costs Rs 400 for all age groups at private centres